CME and CFTC Clash Over On-Chain Perpetual Futures

The US derivatives market is witnessing an unprecedented battle between the CME Group, the largest derivatives exchange operator, and its regulator, the Commodity Futures Trading Commission (CFTC), over the introduction of on-chain perpetual futures. The CFTC recently approved the listing of crypto perpetual futures, also known as perps, which are decentralized derivative contracts that enable users to speculate on the price of an asset with leverage and no expiration date. However, the CME Group has challenged this decision in court, arguing that the CFTC is mislabeling these products and misapplying the law. The CME claims that perps are harmful to its long-dated futures products and that the CFTC's sudden embrace of them did not consider the ramifications. The dispute has significant implications for the US approach to the rapidly growing arena of perpetual futures, with non-US perps volume reportedly reaching $60 trillion in volume last year. The CFTC's decision to allow perps has been seen as a move to open up the US market to these products, but the CME Group's opposition has sparked a heated debate. The CME Group's chairman, Terry Duffy, has argued that the definition of a swap is clear and that perps are, in fact, swaps that require registration with the CFTC and maintenance of five-day margin. He has also expressed concerns that the CFTC may not be prepared to enforce its emerging perps policy properly. The CFTC, on the other hand, has argued that its decision to allow perps is part of its effort to undertake a reasoned analysis of the critical issues at stake. The regulator has also pointed out that the CME Group's attempt to block the listing of perps is an attempt to stifle competition. The dispute is being closely watched by market participants, with some arguing that the CME Group's opposition to perps is typical of the way large incumbents handle innovation that might threaten their dominance. The outcome of the case is likely to have significant implications for the future of the US derivatives market and the regulation of perpetual futures.